Basal Androgens and LH Needing for Ovarian Stimulation for in Vitro Fertilization

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Basing the investigators study on the evidence that basal serum androgens decrease with age, the investigators hypothesize that women with serum androgens below a certain level could be the population obtaining a benefit of Luteinizing Hormone (LH) supplementation. The objective of the present study is to explore the relationship between basal serum androgen levels and the need of LH for Controlled Ovarian Stimulation (COS) in IVF.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
• Treatments: Androgens; Ascorbic Acid; Estrogens, Conjugated (USP); Methyltestosterone

Criteria

Inclusion Criteria:

• 1st-2nd IVF cycle

• Regular cycle (25-35 days)

• Age 18 - 42

• BMI: 18-29.9

Exclusion Criteria:

• LH:FSH > 2

• Low response background (< 5 oocytes)

• Recurrent pregnancy loss

• Preimplantational genetic diagnosis indication

• Any systemic, metabolic or endocrinological disorder.